Sequenom Shares Hammered, Affy's Shares Continue Rebound in April | GenomeWeb

NEW YORK (GenomeWeb News) – Stocks in the GenomeWeb Daily News Index continued their rebound for the second straight month, with Affymetrix rising sharply for the second time in as many months. Meanwhile, Sequenom's shares tumbled on the last day of the month after the firm announced that it would delay the launch of its SEQureDx Down syndrome test due to company employees mishandling R&D test data and results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.